Tine Andersen

Tine Andersen is a seasoned professional with extensive experience in quality assurance and integration within the pharmaceutical industry. Currently serving as the Director of Post-Merger Integration Quality at Novo Nordisk since June 2014, Tine has been pivotal in establishing a strong quality due diligence process for acquisitions in manufacturing. Previous roles include directing Digital Health & Staffs Quality, where Tine led a QA organization focused on developing ISO13485 certified software as medical devices, and overseeing Product Supply Quality Business Support. Tine's career also includes leadership positions at Takeda Pharmaceuticals, managing IT quality assurance for large-scale global IT systems. With a Master of Science in Chemistry from DTU and further qualifications in business and medical instrumentation, Tine has demonstrated expertise in quality management and project leadership across multiple production sites globally.